Skip to main navigation Skip to search Skip to main content

Eltrombopag reduces clinically relevant thrombocytopenic events in higher risk MDS and AML

Research output: Contribution to journal › Comment/debate › peer-review

5   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Eltrombopag reduces clinically relevant thrombocytopenic events in higher risk MDS and AML'. Together they form a unique fingerprint.
Sort by